Financials

News Ideas Technicals Forecast

0RG8 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) operating, investing, and financing activities

Here you can learn where 0RG8 money comes from and how the company spends it.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—